FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Supriya Lifescience IPO and Manyavar IPO.
Supriya Lifescience IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Manyavar IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Supriya Lifescience IPO | Manyavar IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Axis Capital Limited ICICI Securities Limited |
Axis Capital Limited Edelweiss Financial Services Ltd ICICI Securities Limited Iifl Securities Ltd Kotak Mahindra Capital Company Limited |
Registrar | Link Intime India Private Ltd | Kfin Technologies Limited |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Supriya Lifescience IPO is up to ₹700.00 Cr whereas the issue size of the Manyavar IPO is up to ₹3,149.19 Cr. The final issue price of Supriya Lifescience IPO is ₹274.00 per share and of Manyavar IPO is ₹866.00 per share.
Supriya Lifescience IPO | Manyavar IPO | |
---|---|---|
Face Value | ₹2 per share | ₹1 per share |
Issue Price (Lower) | ₹265.00 per share | ₹824.00 per share |
Issue Price (Upper) | ₹274.00 per share | ₹866.00 per share |
Issue Price (Final) | ₹274.00 per share | ₹866.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 54 shares | 17 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | up to ₹200.00 Cr | |
OFS Issue Size | 3,63,64,838 shares | |
OFS Issue Size (Amount) | up to ₹500.00 Cr | up to ₹3,149.19 Cr |
Issue Size Total | 3,63,64,838 shares | |
Issue Size Total (Amount) | up to ₹700.00 Cr | up to ₹3,149.19 Cr |
Supriya Lifescience IPO opens on Dec 16, 2021, while Manyavar IPO opens on Feb 04, 2022. The closing date of Supriya Lifescience IPO and Manyavar IPO is Dec 20, 2021, and Feb 08, 2022, respectively.
Supriya Lifescience IPO | Manyavar IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Dec 16, 2021 | Feb 04, 2022 |
Issue Close | Dec 20, 2021 | Feb 08, 2022 |
Basis Of Allotment (Tentative) | Dec 23, 2021 | Feb 11, 2022 |
Initiation of Refunds (Tentative) | Dec 24, 2021 | Feb 14, 2022 |
Credit of Share (Tentative) | Dec 27, 2021 | Feb 15, 2022 |
Listing date (Tentative) | Dec 28, 2021 | Feb 16, 2022 |
Anchor Lockin End date 1 | Jan 22, 2022 | Mar 13, 2022 |
Anchor Lockin End date 2 | Mar 23, 2022 | May 12, 2022 |
Supriya Lifescience IPO P/E ratio is , as compared to Manyavar IPO P/E ratio of 106.78.
Supriya Lifescience IPO | Manyavar IPO | |||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 99.98% | 92.40% | ||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 68.24% | 84.9% | ||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 106.78 | |||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹21017.37 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Supriya Lifescience IPO retail investors (RII) are offered 26,41,509 shares while in Manyavar IPO retail investors are offered 26,41,509 shares. Qualified institutional buyers (QIB) are offered 79,24,527 shares in Supriya Lifescience IPO and 72,72,968 shares in Manyavar IPO.
Supriya Lifescience IPO | Manyavar IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 79,24,527 shares | 72,72,968 shares |
NII | 39,62,263 shares | 54,54,726 shares |
RII | 26,41,509 shares | 1,27,27,694 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 1,45,28,299 shares | 2,54,55,388 shares |
Supriya Lifescience IPO subscribed 71.51x in total, whereas Manyavar IPO subscribed 2.57x.
Supriya Lifescience IPO | Manyavar IPO | |
---|---|---|
QIB (times) | 31.83x | 7.49x |
NII (times) | 161.22x | 1.07x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 56.01x | 0.39x |
Employee (times) | ||
Other (times) | ||
Total (times) | 71.51x | 2.57x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|